---
title: Andelyn Biosciences vs Viralgen
slug_a: andelynbio
slug_b: viralgen
site: cdmo
review_signal_gate: closed
canonical_path: /compare/andelynbio/viralgen
---

# Andelyn Biosciences vs Viralgen

Side-by-side profile data from each company listing on this directory.

## Andelyn Biosciences

- Profile: [/companies/andelynbio](/companies/andelynbio)

Andelyn Biosciences — Andelyn Biosciences is a gene therapy CDMO offering AAV viral vector manufacturing, plasmid production, process development, analytical development, and quality control for clients. The company reports more than 85 INDs supported and over 500 cGMP batches produced.

Services: 14. Modalities: 3. Indications: 1. Locations: 9. Certifications: 1. The strongest documented coverage currently appears in services (14).

### Services

- Cell-Line Development
- Upstream Processing
- Downstream Processing
- Viral Vector Manufacturing
- AAV Manufacturing
- Lentiviral Vector Manufacturing
- Cell Therapy Manufacturing
- Sterile Fill-Finish & Aseptic Manufacturing
- Process Development
- Technology Transfer
- CMC Analytical Development
- Quality Control Testing
- Stability Testing & Storage
- CMC Regulatory Submission Support

### Modalities

- Cell Therapy
- Gene Therapy
- AAV / Viral Vector Platform

### Development capabilities

- Analytical method development
- Cell line development

### Manufacturing capabilities

- Drug Substance (DS)
- Drug Product (DP)
- Max bioreactor: Mid-scale clinical (≤2,000 L)
- Expression: Mammalian
- Expression: Microbial
- Expression: Viral Vector
- Single-Use / Disposable

## Viralgen

- Profile: [/companies/viralgen](/companies/viralgen)

Viralgen — Viralgen is a CDMO specializing exclusively in cGMP AAV gene therapy manufacturing, with the world's largest dedicated AAV production capacity and a 100% success rate for IND/IMPD dossiers across 50+ gene therapy customers.

Services: 4. Modalities: 2. Indications: 1. Locations: 1. Certifications: 1. The strongest documented coverage currently appears in services (4).

### Services

- Regulatory Affairs
- US FDA Regulatory Strategy
- EU EMA Regulatory Strategy
- Analytical Method Development & Validation

### Modalities

- Gene Therapy
- AAV / Viral Vector Platform

### Development capabilities

- Data not yet provided.

### Manufacturing capabilities

- Data not yet provided.